Accessibility links

Developing Countries to Get Swine Flu Vaccine

Developing Countries to Get Swine Flu Vaccine

Developing Countries to Get Swine Flu Vaccine

<!-- IMAGE -->

The World Health Organization is working on a scheme to make H1N1 Swine Flu vaccines available to poor countries. WHO has just completed a survey of more than 60 developing countries to learn from them how best to help them prepare for the H1N1 pandemic.

For now, the H1N1 swine flu pandemic is relatively mild. But, the World Health Organization warns it might become more severe. It says countries must be prepared for the possibility that the virus will mutate becoming more virulent.

Assistant U.N. Secretary-General and U.N. Coordinator on Avian and Pandemic Influenza, David Nabarro says the pandemic could last two years, so nations must be prepared for the long haul.

He says U.N. agencies are working on a plan to support developing countries get the help they need to protect their populations from the pandemic. He says the plan is based on the priorities expressed by the countries themselves.

He says the plan aims to prevent excess mortality, keep the negative social impact from the disease to a minimum and make health systems stronger so countries can protect themselves from the current and future pandemics.

He says poor countries want access to H1N1 vaccines and anti-virals such as Tamiflu. He says given the shortage of the vaccine, it is necessary to establish a system that will enable all countries to get a basic share of the available vaccine.

"There will be a system established through which around 10 percent of world vaccine production and anti-H1N1 vaccine production will be obtained by WHO and made available to countries on a basis that is proportional to their populations for them primarily to protect health care personnel and other essential workers," said Dr. Nabarro. "And, then once that has been set up and established, countries will be supported to do this and also to access vaccine to help protect other high risk individuals."

Nabarro says nine countries so far have pledged to donate 10 percent of their stock of H1N1 vaccines to the World Health Organization for distribution to poor countries. He says other countries also are expected to join in.

Besides this, he says WHO is soliciting vaccine donations from a number of pharmaceutical companies and is prepared to buy vaccines at a low price to fill in any gaps.

To date, WHO reportedly has received 150 million vaccine donations from manufacturers, plus another 50 million doses from the nine countries. The health agency says it would like to have a stockpile of 300 million doses of the vaccine.

Dr. Nabarro says it is difficult to know how WHO will allocate scarce supplies of vaccine among the developing countries in a fair and equitable manner.

"The judgment that will be made by WHO will be around a set of issues that have to be considered," he said. "One will be what is the pandemic doing, where is it going, who is it affecting, the kind of epidemiological data. How ready is a country to be able to administer the vaccine to the group that is being prioritized."

Nabarro says countries also will have to fulfill a number of legal requirements on liability and licensing. He notes this is the normal procedure with any medicine and other preparation that is donated.

About 25 different manufacturers are reportedly set to donate or sell low-cost vaccines to WHO. Health officials say each country will receive vaccines from one specific company In order to avoid confusion and to simplify the monitoring process.